Status: Recruiting
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
The aim for this clinical trial is to evaluate if colchicine in addition to standard of care improves insulin sensitivity in individuals with type 1 diabetes, systemic low-grade inflammaiton and reduced insulin sensitivity. The insulin sensitivity will be evaluated by a hyperinsulinemic, euglycemic clamp.
Participants needed: 26
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Asger Lund, MDUpdated: Dec 23, 2025Locations: 1
Eligibility criteria
Type 1 diabetes for more than five years according to World Health Organization... [+7]
Hypoglycaemia unawareness (inability to register low blood glucose) ad modum Ped... [+28]